January 3

Moderna soars on analyst upgrade

0 comments

This post was originally published on this site

Moderna’s stock surges on positive analyst outlook, reflecting the potential of its innovative mRNA-based vaccines and therapies.

This Is What Black Friday and Holiday Shoppers Are Really Looking for This Season, According to New Research